GMP Compliance Consulting: What to Expect, How to Prepare

Most companies don't call a GMP consultant because they're curious about quality systems. They call because something forced the issue: an FDA Form 483, a failed BRCGS audit, a new facility that needs to be operational before a customer's next purchase order, or a quality manager who just quit and took the institutional knowledge with her. By the time I get the call, the question isn't "should we invest in compliance" — it's "how fast can this get fixed, and what's actually going to happen to my operation while it does."

This guide answers both. It walks through what a GMP compliance consulting engagement actually looks like phase by phase, what a consultant is going to ask you for before they ever walk your floor, and where these projects typically go sideways. If you're evaluating whether to bring someone in — or you've already signed the engagement letter and want to know what's coming — this is the reference to bookmark.

What GMP Compliance Consulting Actually Involves

GMP compliance consulting is the practice of assessing a facility's manufacturing, quality, and documentation systems against the applicable Good Manufacturing Practice regulation — 21 CFR Part 211 for finished drugs, 21 CFR Part 111 for dietary supplements, 21 CFR Part 820 (now largely harmonized with ISO 13485 under the Quality Management System Regulation) for devices, or ICH Q7 for active pharmaceutical ingredients — and then closing the gaps between where the facility stands and where the regulation requires it to be.

That sounds like one job. It's really three, and conflating them is where a lot of engagements go wrong. There's the diagnostic work (finding out what's wrong), the remediation work (fixing it), and the readiness work (proving it's fixed to someone with authority to shut you down if they disagree). A consultant who's good at one of these isn't automatically good at the other two, and you should ask which one you're actually hiring for before the contract is signed.

When Companies Bring In a GMP Consultant

In my experience, engagements cluster around a handful of triggers, and the trigger determines the shape of the engagement more than anything else does:

• A Form 483 or warning letter. The company has already been inspected, findings were issued, and there's a regulatory clock running on the response.
• A scheduled inspection or third-party audit. FDA has announced (or is overdue for) a routine inspection, or a customer requires BRCGS, SQF, or FSSC 22000 certification before they'll place a purchase order.
• A new facility or product line. The quality system doesn't exist yet, or exists only on paper.
• Loss of internal quality leadership. The person who held the regulatory relationships and institutional memory has left, and nobody behind them can speak to why the SOPs say what they say.
• A customer or investor due-diligence requirement. Someone downstream is underwriting risk and wants an independent read on the quality system before they commit capital or volume.

The FDA's own enforcement data makes the stakes concrete. An analysis of the warning letters FDA issued to drug manufacturers in 2025 found that weak documentation, inadequate process control, and data integrity gaps — backdated records, missing audit trails, unexplained discrepancies never investigated — accounted for the majority of citations, and that pattern has held steady across recent enforcement cycles. Under 21 CFR 211.192, any unexplained discrepancy or batch failure requires a written investigation regardless of whether the batch has already shipped, and that single clause is responsible for more findings than almost any other provision in the regulation, because it's the one most quality units treat as optional until an investigator points out that it isn't.

What to Expect: The Engagement Lifecycle

A properly scoped GMP consulting engagement moves through five phases. Not every engagement needs all five — a company two weeks from an FDA inspection doesn't have time for a leisurely gap assessment — but understanding the full lifecycle tells you what's being skipped and why.

Phase 1: Gap Assessment

This is diagnostic, not corrective. A consultant reviews your SOPs, batch records, deviation logs, training records, and facility layout against the applicable regulation clause by clause, and produces a scored list of gaps — typically ranked by regulatory severity (would this likely trigger a 483 observation, and at what classification) rather than by how easy it is to fix. A gap assessment produces no citations and carries no regulatory weight; its only purpose is to tell you where you actually stand before someone with the authority to cite you shows up and tells you instead.

Phase 2: Remediation Roadmap

The gap list becomes a corrective action plan: root cause identified for each finding, an owner assigned, a target date, and — critically — the objective evidence that will demonstrate the fix actually worked. The single most common reason a remediation project runs long isn't the correction itself. It's that the CAPA got written before anyone determined the actual root cause, so the fix addresses the symptom and the same finding reappears at the next audit under a different clause number.

Phase 3: Implementation and Training

SOPs get rewritten, not just edited. Staff get trained on the new procedures, and that training gets documented — because an untrained-on procedure is, from an inspector's perspective, functionally identical to no procedure at all. This phase also covers validation work where applicable: equipment qualification, cleaning validation, computer system validation for anything touching electronic batch records under 21 CFR Part 11.

Phase 4: Mock Audit and Readiness Review

Before the real inspection or third-party audit, a consultant runs a simulated version of it — walking the floor, pulling records at random the way an investigator would, interviewing operators cold. Findings get scored by severity the same way a real citation would be, which is the point: you want to discover your weakest answer in a mock audit, not in front of an FDA investigator or a BRCGS auditor holding your certification.

Phase 5: Ongoing or Fractional Support

Some companies don't need — or can't yet justify — a full-time quality or regulatory hire. A fractional QA/RA arrangement puts an experienced person into monthly cadence: reviewing deviations, chairing the management review meeting required under most quality systems, keeping the CAPA log from going stale between audits.

Comparison: Which Engagement Type Fits Your Situation

GMP and the GFSI/BRCGS Overlap

A large share of the companies searching for GMP compliance consulting right now aren't drug manufacturers at all — they're food, beverage, and dietary supplement facilities trying to satisfy a retailer or brand-owner requirement for GFSI-recognized certification, most often BRCGS. The two frameworks aren't the same thing, but they overlap enough that treating them separately wastes money.

GMP under 21 CFR Part 117 (for food) or Part 111 (for supplements) is the regulatory floor — what FDA requires. GFSI is a private benchmarking framework that recognizes several certification schemes, including BRCGS, SQF, and FSSC 22000, as meeting a common baseline of rigor; retailers and brand owners use GFSI recognition as their supplier-qualification shortcut instead of auditing every vendor themselves. BRCGS Food Safety Issue 9 is the current version of the most widely held of those schemes, and it only received GFSI recognition on August 23, 2024 — certificates issued against Issue 9 before that date don't count as GFSI-recognized, a transition detail that's tripped up more than a few facilities that assumed any current certificate would satisfy their customer's requirement. More than 17,000 sites worldwide currently hold BRC certification, which tells you how deeply embedded the scheme already is in food and supplement supply chains — and how little competitive advantage certification alone provides, since your competitors mostly have it too.

The practical takeaway: if you're a food or supplement manufacturer, your GMP program and your GFSI-scheme documentation should be built as one system with two audiences, not two separate compliance projects running on parallel tracks. A consultant who only knows 21 CFR Part 117 and doesn't know BRCGS Issue 9's documentation and management-commitment requirements will leave you rebuilding half your paperwork twice.

How to Prepare Before Your First Consulting Engagement

The single biggest lever you control over how fast and how expensive this goes is how prepared you are before the consultant's first site visit. Here's what to have ready:

1. Your current SOP library, indexed. Not a folder of loose files — a list of every procedure, its revision date, and its owner. If you don't know how many SOPs you have, that's itself a finding.
2. The last two years of internal audit reports and any external audit or inspection reports, including every 483, warning letter response, or third-party nonconformance and how it was closed.
3. Your deviation and CAPA log, ideally with status (open, closed, overdue) visible at a glance.
4. Training records mapped to current SOP versions — not just a signature sheet, but proof the training content matched what was actually being trained on at the time.
5. An organizational chart with quality authority marked, so the consultant knows who actually has sign-off authority under 21 CFR 211.22's quality control unit requirement, versus who just has the title.
6. A facility walk-through scheduled for day one, not day three. Consultants find things by looking at the floor, not just the paperwork, and the sooner that happens the sooner the real gap list starts forming.
7. Internal buy-in from whoever owns the budget. A remediation plan that dies in a budget meeting because nobody above the quality manager knew it was coming is the most common cause of a stalled engagement I see, and it has nothing to do with the technical findings.

What Documentation a Consultant Will Ask For First

Expect the initial document request to include, at minimum: the site quality manual, batch or production records for the last several lots, the master validation plan (if one exists), equipment calibration and maintenance logs, supplier qualification files for critical raw materials, and the complaint-handling log. If you're pursuing GFSI-recognized certification, add your HACCP or food safety plan, allergen control program, and the site's most recent internal audit against the BRCGS or SQF standard itself. Gathering this before the engagement starts, rather than during it, is usually the difference between a three-week gap assessment and a six-week one — the delay is almost never the analysis, it's the document hunt.

Common Pitfalls That Extend Timelines

• Treating the CAPA as a checkbox instead of a root-cause exercise. A corrective action that doesn't address why the failure happened will show up again, usually cited under a different clause, at the next audit.
• Assuming a passed audit means the system is fixed. Auditors sample. A clean audit tells you the sample was clean, not that every batch record behind it would hold up to the same scrutiny.
• Under-resourcing the quality unit while it's absorbing new procedures. Training takes real hours from real people. Scheduling remediation on top of a full production calendar with no relief is how good SOPs get signed off without being understood.
• Skipping the mock audit to save time. This is the step most likely to get cut under budget pressure, and it's the one most likely to be the difference between a clean inspection and a 483.

Frequently Asked Questions

How long does a GMP compliance consulting engagement typically take?

A standalone gap assessment usually runs one to three weeks. Full remediation, including SOP rewrites and staff training, typically runs three to six months depending on how many findings there are and how much of the quality system has to be rebuilt versus patched.

What's the difference between a gap assessment and a mock audit?

A gap assessment is a document and process review against the regulation, done early, to build the initial finding list. A mock audit is a simulated inspection, done near the end of remediation, that tests whether the fixes will actually hold up when someone unfamiliar with your facility starts asking questions and pulling records at random.

Do I need a GMP consultant if I'm only preparing for a BRCGS or SQF audit?

Yes, if you manufacture food, beverage, or dietary supplements, because your underlying GMP program (21 CFR Part 117 or Part 111) is the foundation the GFSI-recognized scheme builds on. Treating the regulatory GMP requirement and the customer-driven certification as separate projects usually means rebuilding the same documentation twice.

Can a GMP consultant represent my company during an actual FDA inspection?

A consultant can prepare your team, coach the people who will be in the room, and be present to advise during the inspection, but FDA interacts directly with your employees and your management — a consultant doesn't stand in for company representatives during the inspection itself.

What happens if the consultant's gap assessment finds more problems than we expected?

That's common, and it's the reason to do the assessment before an audit rather than discover the same gaps from an FDA investigator or third-party auditor. A larger-than-expected finding list gets triaged by severity, and remediation typically starts with whatever would trigger the most serious citation first.

If you're weighing whether to start with a scoped gap assessment or need help sorting out which engagement type actually fits your situation, reach out to Certify Consulting and we can talk through where your facility stands before you commit to a full remediation budget.

Last updated: 2026-08-03